BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32529807)

  • 21. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation using microphysiometry of CRF receptor pharmacology.
    Smart D; Coppell A; Rossant C; Hall M; McKnight AT
    Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
    Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
    Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
    Dautzenberg FM; Gutknecht E; Van der Linden I; Olivares-Reyes JA; Dürrenberger F; Hauger RL
    Biochem Pharmacol; 2004 Nov; 68(9):1833-44. PubMed ID: 15450949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of CRF and urocortins on the sociability of mice.
    Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G
    Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells.
    Kageyama K; Murasawa S; Niioka K; Otsuka F; Yagi H; Daimon M
    Neurosci Lett; 2017 Nov; 660():63-67. PubMed ID: 28851616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.
    Mahajan S; Liao M; Barkan P; Takahashi K; Bhargava A
    Peptides; 2014 Apr; 54():58-66. PubMed ID: 24462512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
    Henry B; Vale W; Markou A
    J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.
    Liu J; Yu B; Neugebauer V; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
    J Neurosci; 2004 Apr; 24(16):4020-9. PubMed ID: 15102917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
    Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
    Psychopharmacology (Berl); 2012 Apr; 220(3):599-610. PubMed ID: 21947356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
    Verleye M; André N; Gillardin JM
    Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
    Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
    J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CRF peptide family and their receptors: yet more partners discovered.
    Dautzenberg FM; Hauger RL
    Trends Pharmacol Sci; 2002 Feb; 23(2):71-7. PubMed ID: 11830263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of stress-related peptides on chloride secretion in the mouse proximal colon.
    Liu S; Karo A; Agterberg S; Hua H; Bhargava A
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14021. PubMed ID: 33118282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.